Zefeng Xu

5.0k total citations
169 papers, 1.8k citations indexed

About

Zefeng Xu is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Zefeng Xu has authored 169 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Hematology, 65 papers in Genetics and 52 papers in Molecular Biology. Recurrent topics in Zefeng Xu's work include Acute Myeloid Leukemia Research (75 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (56 papers) and Kruppel-like factors research (20 papers). Zefeng Xu is often cited by papers focused on Acute Myeloid Leukemia Research (75 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (56 papers) and Kruppel-like factors research (20 papers). Zefeng Xu collaborates with scholars based in China, United States and United Kingdom. Zefeng Xu's co-authors include Liqiang Zheng, Zhaoqing Sun, Xingang Zhang, Dayi Hu, Tiejun Qin, Jue Li, Jiajin Li, Shuangshuang Liu, Zhijian Xiao and Robert Peter Gale and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Zefeng Xu

150 papers receiving 1.8k citations

Peers

Countries citing papers authored by Zefeng Xu

Since Specialization

Citations

This map shows the geographic impact of Zefeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zefeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zefeng Xu more than expected).

Fields of papers citing papers by Zefeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zefeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zefeng Xu. The network helps show where Zefeng Xu may publish in the future.

Co-authorship network of co-authors of Zefeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zefeng Xu. A scholar is included among the top collaborators of Zefeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zefeng Xu. Zefeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical analysis of sustained-release 5-fluorouracil implants during surgery for advanced gastric cancer 2025 ·Current Problems in Surgery ·(unknown), Ying Xie, Zhenyu Jiang, Zefeng Xu, (unknown), (unknown)	2
2	INS018-055, A Novel Traf2- and NCK-interacting Kinase (TNIK) Inhibitor, Improves Lung Function in Patients With Idiopathic Pulmonary Fibrosis: Results From a Randomized, Double-blind, Placebo-controlled Phase 2a Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·Zefeng Xu, Ping Wang, Jie Cao, Tan Chen, Dedong Ma, Lijin Zhao, Toby M. Maher, Alex Zhavoronkov, Feng Ren, Shodhan Rao, Carol Satler, Simin Liu, Yinghua Lv, Hongyu Zhao, Alexander Aliper	0
3	Magnetic Hydrogel: Enhanced Bacterial Biosensor for Speedy Gut Disease Detection 2025 ·ACS Sensors ·Zefeng Xu, Jing Mi, Jing‐Feng Zhao, Yanlin Zhu, Yuhou Wu, (unknown), (unknown), Bang‐Ce Ye, Ying Zhou	0
4	Modular brain-machine interface for neurorecording, neurostimulation, and drug delivery 2025 ·Device ·Tian‐Lu Sheng, (unknown), Jingwei Li, (unknown), Xiaolong Wang, (unknown), Hongru Liu, Zefeng Xu, (unknown), Guo Yong, Jing Xu, Lianqing Liu, (unknown)	1
5	ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms. 2023 ·PubMed ·(unknown), Jinqin Liu, Yingying Zhao, (unknown), (unknown), Peihong Zhang, Zefeng Xu, Tiejun Qin, Shiqiang Qu, Lijuan Pan, (unknown), (unknown), Zexing Li, Wenjun Zhang, (unknown), Huijun Huang, (unknown), Bing Li, Xudong Wu, Zhijian Xiao	4
6	Clinical and molecular characteristics of forty Chinese children with essential thrombocythemia: A single‐center, retrospective analysis 2023 ·British Journal of Haematology ·(unknown), (unknown), Zhenping Chen, Tianyuan Hu, Zefeng Xu, (unknown), Rongfeng Fu, (unknown), (unknown), Xiaofan Zhu	2
7	Carvacrol induces osteogenic differentiation of BMSCs and alleviates osteolysis in aged mice by upregulating lncRNA NEAT1 to promote SIRT1 expression 2023 ·Zefeng Xu, Zeyu Wang, (unknown), Zhihui Huang	8
8	U2AF1 S34F Mutation Promote Megakaryopoiesis and Fibrogenesis in MDS 2023 ·Blood ·Wenjun Zhang, Jinqin Liu, Lin Yang, (unknown), Tiejun Qin, Zefeng Xu, (unknown), Bing Li, Zhijian Xiao	0
9	PTBP1 is necessary for dendritic cells to regulate T‐cell homeostasis and antitumour immunity 2021 ·Immunology ·Guangfeng Geng, Zefeng Xu, Nan Peng, Yue Li, Jinhua Liu, Jing Wu, Jing Liang, Yushan Zhu, Lihong Shi	20
10	The value of fragmented QRS in predicting the prognosis of chronic total occlusion patients with myocardial infarction history undergoing percutaneous coronary intervention: A 24‐months follow‐up study 2021 ·Clinical Cardiology ·(unknown), Xi Fu, (unknown), Jie Chen, Zefeng Xu, Xiaoxia Liu, (unknown)	3
11	Receptor-mediated mitophagy regulates EPO production and protects against renal anemia 2021 ·eLife ·Guangfeng Geng, Jinhua Liu, Zefeng Xu, (unknown), Linbo Chen, Chenglong Mu, (unknown), Jie Gao, Yue Li, (unknown), Tian Zhao, Chuanmei Zhang, Jiaxi Zhou, Quan Chen, Yushan Zhu, Lihong Shi	17
12	Non‐ST‐elevated myocardial infarction with “N” wave on electrocardiogram and culprit vessel in left circumflex has a risk equivalent to ST‐elevated myocardial infarction 2020 ·Clinical Cardiology ·(unknown), Jie Chen, Xiaoxia Liu, Zefeng Xu, (unknown), Xi Fu, (unknown)	3
13	[Mean corpuscular volume ≤100 fl was an independent prognostic factor in patients with myelodysplastic syndrome and bone marrow blast<5 percent]. 2020 ·PubMed Central ·(unknown), Tiejun Qin, Zefeng Xu, Huijun Huang, Bing Li, Shiqiang Qu, Naibo Hu, Lijuan Pan, Dan Liu, (unknown), Yudi Zhang, Zhijian Xiao	1
14	Clinical Features and Biological Implications of U2AF1 Mutations in Myelodysplastic Syndromes 2017 ·Blood ·Bing Li, Jinqin Liu, Yujiao Jia, Tiejun Qin, Zefeng Xu, Yue Zhang, Gang Huang, Zhijian Xiao	2
15	HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis 2017 ·Blood ·Yoshihiro Hayashi, Rui Huang, Xiaomei Yan, Jiachen Bu, Jieyu Wang, Yue Zhang, Yile Zhou, Yuting Tang, Lingyun Wu, Zefeng Xu, Xin Liu, Qianfei Wang, Jianfeng Zhou, Zhijian Xiao, (unknown), Rebecca Marsh, Kejian Zhang, Michael B. Jordan, Yuhua Li, Gang Huang	3
16	TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia 2016 ·PubMed ·Yajuan Cui, Hongyan Tong, Xin Du, Bing Li, Robert Peter Gale, Tiejun Qin, Jinqin Liu, Zefeng Xu, Yue Zhang, Gang Huang, Jie Jin, Liwei Fang, Hongli Zhang, Lijuan Pan, Naibo Hu, Shiqiang Qu, Zhijian Xiao	9
17	Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia 2015 ·Experimental Hematology and Oncology ·Yajuan Cui, Hongyan Tong, Xin Du, Bing Li, Robert Peter Gale, Tiejun Qin, Jinqin Liu, Zefeng Xu, Yue Zhang, Gang Huang, Jie Jin, Liwei Fang, Hongli Zhang, Lijuan Pan, Naibo Hu, Shiqiang Qu, (unknown)	29
18	Unique features of primary myelofibrosis in Chinese 2012 ·Blood ·Zefeng Xu, Robert Peter Gale, Yue Zhang, Tiejun Qin, (unknown), Peihong Zhang, Tianjiao Zhang, Liu Liu, Shiqiang Qu, Zhijian Xiao	22
19	Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study 2011 ·Leukemia & lymphoma ·Shiqiang Qu, Zefeng Xu, Yue Zhang, Tiejun Qin, (unknown), Rui Cui, (unknown)	14
20	Differential Control of Systolic and Diastolic Blood Pressure: Factors Associated With Lack of Blood Pressure Control in Rural Community of Liaoning Province, China 2007 ·JOURNAL OF HEALTH SCIENCE ·Liqiang Zheng, Jue Li, Zhaoqing Sun, Jinming Yu, Xinzhong Zhang, Xingang Zhang, Shuangshuang Liu, Dayi Hu, Zefeng Xu, Jiajin Li, (unknown), Rui Zhang, Yingxian Sun	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact